The University of Rochester's Radiation Oncology residency program was recently approved to increase its size from 6 to 8 residents. In our application to increase the number of our residency spots, we described our increase in patient numbers we have had over the past few years as well as our commitment to education of our current residents.
Currently we are recruiting additional resident(s) outside of the match, to start July 1, 2013, and plan to recruit future residents within the match.
The University of Rochester's main Radiation Oncology site is at Strong Memorial Hospital within the James P. Wilmot Cancer Center. We moved into our current site on the ground floor of the Cancer Center in 2008. In 2012, the Cancer Center was expanded to include inpatient wards on the 6th and 7th floors. The first floor of the Cancer Centers houses the multidisciplinary clinics and the other floors house research labs and offices. Adjacent to the Cancer Center is the construction site for the new Golisano Children's Hospital, which will be a state of the art pediatric inpatient and outpatient facility.
Treatment machines at Strong Memorial Hospital include Tomotherapy, Novalis, Trilogy, 2 other Varian LINACS, and 2 unused vaults allowing for future expansion. Highland Hospital, located 1.5 miles from Strong Memorial Hospital, is another University of Rochester affiliated hospital where our residents rotate. Our high dose rate brachytherapy machine is located there.
Residents gain expertise in IMRT, IGRT, total body and total marrow irradiation, SRS, SBRT/SABR, radioembolization (Y-90), unsealed sources, HDR brachytherapy, interstitial brahytherapy, and pediatric oncology. Generally, residents cover 1 attending for a block of 2-3 months. A resident may cover 2 attendings if both have a 20-50% clinical service (i.e. other time committed to funded research or coverage of satellite offices). Our Department employs 4 physician assistants (one at Highland Hospital) who provide coverage of services without a resident as well as cross-coverage and triage services.
Didactic lectures are provided for radiation biology, physics, dosimetry and clinical radiation oncology. Other educational opportunities include journal clubs, cancer survivorship workshops, chart rounds and weekly, resident run, case-based presentations.
Residents receive at least 6 months of elective time, all of which can be used for research. Some residents opt to rotate at one of our 3 private practice satellites (residents are not required to rotate at these satellites).
The University of Rochester's Chair is Dr. Yuhchyau Chen, MD PhD. Her clinical interests include thoracic and head and neck malignancies. Her research interests include cytokine analyses to predict radiation toxicity and bone marrow genotoxicity; she currently is funded by a Biomedical Advanced Research and Development Authority (BARDA) contract to develop drugs to treat radiation-induced bone marrow injury.
http://www.urmc.rochester.edu/news/story/index.cfm?id=3389
Dr. Louis Constine, MD, our Vice Chair, is an internationally recognized leader in pediatric oncology, sarcoma and hematologic malignancies, as well as late effects of cancer treatment. He holds several leadership positions in national and international societies. He is involved in a multitude of clinical research projects.
In addition to research opportunities with the clinical faculty, residents can participate in translational and basic science research with other prominent faculty. Jacqueline Williams, PhD, who is President of the Radiation Research Society, currently heads the Center for Medical Countermeasures against Radiation – a multi-project U-19 grant to study radiation injury. (
http://radoncu19.urmc.rochester.edu/)
Dr. Lois Travis, MD ScD heads the Cancer Survivorship research division. She, along with colleagues in the NCI-funded Community Clinical Oncology Program (
http://urcc-ccop.com/ccop/) have office space in University of Rochester's Clinical & Translational Science Institute (
http://www.urmc.rochester.edu/ctsi/), one of ~10 NCI funded Translational Institutes.
Several faculty in other departments (such as Environmental Medicine, Immunology, Biochemistry and Biophysics) also have research interests in radiation biology.
We are now accepting applications for a resident to start July 1, 2013 (outside of the match).
Requirements include the following:
- Updated curriculum vitae
- 3 letters of reference
- Medical school transcript and Dean's letter
- USMLE Transcript (Steps 1 and 2 are required)
- Personal statement
- Completion of an ACGME approved internship
- No contractual obligations to another program, or applicant's current Program Director's and Dean for Graduate Medical Education's approval to accept a position at Rochester
Interested applicants are asked to email Susan Fritsch, our program coordinator. Her contact information can be found at:
http://www.urmc.rochester.edu/educa...applicant-information/contact-information.cfm
Michael T. Milano, MD PhD
Associate Professor
Residency Program Director
6/28/13 EDIT: Both positions have been filled.